Abstract | BACKGROUND: The inhibition of thiopurine methyltransferase activity, one of the enzymes responsible for azathioprine metabolism, by aminosalicylates has been described in an in vitro study. This could result in a higher risk of bone marrow depression when using the two drugs together. AIM: METHODS: RESULTS: CONCLUSIONS: This in vivo study favours the existence of an interaction between azathioprine and aminosalicylates through a mechanism which remains unclear. This drug-drug interaction should be taken into account when using azathioprine and aminosalicylates simultaneously.
|
Authors | O Dewit, R Vanheuverzwyn, J P Desager, Y Horsmans |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 16
Issue 1
Pg. 79-85
(Jan 2002)
ISSN: 0269-2813 [Print] England |
PMID | 11856081
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Biomarkers
- Guanine Nucleotides
- Immunosuppressive Agents
- Thionucleotides
- 6-thioguanylic acid
- Sulfasalazine
- Mesalamine
- Methyltransferases
- thiopurine methyltransferase
- Azathioprine
|
Topics |
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects, pharmacology)
- Azathioprine
(adverse effects, pharmacology)
- Biomarkers
(analysis)
- Crohn Disease
(drug therapy)
- Drug Interactions
- Female
- Guanine Nucleotides
(blood)
- Humans
- Immunosuppressive Agents
(adverse effects, pharmacology)
- Male
- Mesalamine
(adverse effects, metabolism, pharmacology)
- Methyltransferases
(metabolism)
- Middle Aged
- Sulfasalazine
(adverse effects, pharmacology)
- Thionucleotides
(blood)
|